25.80
+0.14(+0.55%)
Currency In USD
| Previous Close | 25.66 |
| Open | 26.14 |
| Day High | 26.55 |
| Day Low | 25.64 |
| 52-Week High | 40.47 |
| 52-Week Low | 14.8 |
| Volume | 827,054 |
| Average Volume | 1.4M |
| Market Cap | 1.97B |
| PE | -17.2 |
| EPS | -1.5 |
| Moving Average 50 Days | 24.84 |
| Moving Average 200 Days | 29.68 |
| Change | 0.14 |
CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire Inc.
Jun 05, 2025 12:00 PM GMT
IRVINE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder
CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
GlobeNewswire Inc.
May 15, 2025 12:00 PM GMT
IRVINE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder
SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
GlobeNewswire Inc.
May 01, 2025 12:00 PM GMT
- Award recipients Honored at the American Urological Association's 2025 Annual Meeting - - Fellowship designed to support the development of outstanding clinical cancer research investigators to improve the understanding and treatment of NMIBC - SCH